PATENT CLAIM ANALYSIS

Application Number: 16042917
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["435", "366000"]

Abstract:
Disclosed herein are methods, compositions, kits, and agents useful for inducing β cell maturation, and isolated populations of SC-β cells for use in various applications, such as cell therapy.

Claim (Index 20):
The method of  claim 19 , wherein the subject is diabetic.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14684101', '14975158', '15478094', '14670249', '12167227']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6411899598191956
- 35 USC 102 Novelty (BERT): 0.594010922016398
- Combined Prediction Score: 0.6364720560389159
- Mean Citation Score: 422.614236
- Max Citation Score: 630.4137599999998
- Similarity Product: 418.3534478559493

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test